Your browser doesn't support javascript.
loading
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont, Alexander M M; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; van den Eertwegh, Alfonsus J M; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C; van Akkooi, Alexander C J; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan; Robert, Caroline.
Afiliación
  • Eggermont AMM; Princess Máxima Center, Utrecht, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands. Electronic address: alexander.eggermont@prinsesmaximacentrum.nl.
  • Blank CU; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands.
  • Mandalà M; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Long GV; Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals, Sydney, NSW, Australia.
  • Atkinson VG; Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Dalle S; Hospices Civils de Lyon Cancer Institute, Lyon, France.
  • Haydon AM; Alfred Hospital, Melbourne, VIC, Australia.
  • Meshcheryakov A; NN Blokhin Cancer Research Center, Moscow, Russia.
  • Khattak A; Fiona Stanley Hospital & Edith Cowan University, Perth, WA, Australia.
  • Carlino MS; Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia.
  • Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Larkin J; Royal Marsden Hospital, London, UK.
  • Puig S; Hospital Clinic de Barcelona, Universitat de Barcelona, Spain & Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain.
  • Ascierto PA; Istituto Nazionale Tumori IRCCS "Fondazione G Pascale", Naples, Italy.
  • Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Schadendorf D; University Hospital Essen, Essen and German Cancer Consortium, Heidelberg, Germany.
  • Koornstra R; Radboud University Medical Center Nijmegen, Nijmegen, Netherlands.
  • Hernandez-Aya L; Washington University School of Medicine, St Louis, MO, USA.
  • Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
  • van den Eertwegh AJM; Amsterdam University Medical Center, VUMC, Amsterdam, Netherlands.
  • Grob JJ; Aix Marseille University, Hôpital de la Timone, Marseille, France.
  • Gutzmer R; Skin Cancer Center, Hannover Medical School, Hannover, Germany.
  • Jamal R; Centre Hospitalier de l'Université de Montréal (CHUM), Centre de recherche du CHUM, Montreal, QC, Canada.
  • Lorigan PC; Christie NHS Foundation Trust, Manchester, UK.
  • van Akkooi ACJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands.
  • Krepler C; Merck & Co, Kenilworth, NJ, USA.
  • Ibrahim N; Merck & Co, Kenilworth, NJ, USA.
  • Marreaud S; EORTC Headquarters, Brussels, Belgium.
  • Kicinski M; EORTC Headquarters, Brussels, Belgium.
  • Suciu S; EORTC Headquarters, Brussels, Belgium.
  • Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France.
Lancet Oncol ; 22(5): 643-654, 2021 05.
Article en En | MEDLINE | ID: mdl-33857412
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Clinical_trials Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Clinical_trials Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article